AroCell AB (publ) announced that Ellen Dittberner will be on parental leave from her position as Chief Financial Officer (CFO) starting on February 1, 2024. During this period, Lars Jakobsson will serve as the acting CFO. Lars has previously held the position of CFO at IDL Biotech and AroCell AB from 2017 to 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.372 SEK | +0.54% | -3.88% | -14.87% |
Apr. 18 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
Feb. 22 | AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.87% | 7.82M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AROC Stock
- News AroCell AB
- AroCell AB Announces Chief Financial Officer Changes